medigraphic.com
ISSN 1995-9427 (Print)

2014, Number 1

<< Back Next >>

Invest Medicoquir 2014; 6 (1)

Lymphomas and rheumatoid diseases

Luna CCM, Figueredo PYE, Wilford LM, Reyes LAG, Hernández MA, Sabatier CA

Language: Spanish
References: 14
Page: 98-106
PDF size: 262.80 Kb.


ABSTRACT

Lymphomas are cancers that originate in the cells of the immune system and are divided into two groups, Hodgkin's disease and non-Hodgkin lymphoma. They represent 4 % of all deaths from cancer. The increased incidence of lymphomas associated to rheumatoid diseases in related with immunodeficiency and autoimmunity states. We review these subject from the presentation of two female patients, 25 and 61 years old, with diagnosis of lymphoma´s disease associated with reactive arthritis and psoriatic respectively.


REFERENCES

  1. Paul C, Le Tourmeau A, Cayuela JM, Devidas A, Robert C, Molinié V, et al. Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis. Arch Dermatol 1997;133(7):867-71. Disponible en: URL: http://www.ncbi.nlm.nih.gov/pubmed/

  2. Kamel OW, Van de Rijn M, Weiss LM, Del Zoppo GJ, Hench PK, Robbins BA, et al. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med. 1993;328(18):1317-21.

  3. Ekström K, Hjalgrim H, Brandt L, Baecklund E, Klareskog L, Ekbom A, et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum. 2003;48(4):963-70.

  4. Georgescu L, Quinn GC, Schwartzman S, Paget SA. Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment. Medicine 2001;2:350-56.

  5. Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J, et al. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood. 2002;99(11):3909-15.

  6. Harris NL, Swerdlow SH. Methotrexate-associated lymphoproliferative disorders. En: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press 2001;p. 270-1.

  7. Thomson GT, Keystone EC, Sturgeon JF. Erythema nodosum and –Hodgkin’s lymphoma. J Rheumatol. 1990;17:383-85.

  8. Caldwell D. Musculoskeletal syndromes associated with malignancy. Textbook of Rheuamatology. 4th Ed. Philadelphia 1993. p. 94.

  9. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R. Increased risk of lymphoma in sicca syndrome. Ann Intern Med. 1978;89:888-92.

  10. Kelly C, Sykes H. Rheumatoid arthritis, malignancy and paraproteins. Ann Rheum Dis. 1990;49:657-59.

  11. Loprinzi CL, Duffy J, Ingle JN. Postchemotherapy rheumatism. J Clin Oncol. 1993;11:768-70.

  12. Husni ME. Psoriatic arthritis. Cleveland Clinic. 2nd Ed. Current Clinical Medicine. Philadelphia, 2010. Elsevier.p.123-45.

  13. Pérez A. Medicina Clínica. Artritis reumatoide, metotrexato y linfoma no hodgkiniano. Estudio de 3 pacientes. Med Clin Barc. 2005;125(16):637.

  14. Szekanecz Z, Szekanecz E, Shoenfeld Y. Malignancies in Autoinmune Rheumatic Desease. A Mini-Review. Gerontology 2011;57:3-10.




2020     |     www.medigraphic.com